HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Belhadj Selected Research

K Belhadj Research Topics

Disease

3Hodgkin Disease (Hodgkin's Disease)
07/2016 - 04/2001
3Lymphoma (Lymphomas)
03/2014 - 06/2001
3B-Cell Lymphoma (Lymphoma, B Cell)
08/2007 - 04/2003
2Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2004 - 06/2001
1Neoplasms (Cancer)
03/2014
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
03/2014
1Chromosome Aberrations (Chromosome Abnormalities)
03/2010
1Multiple Myeloma
03/2010
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2009
1Sinus Tachycardia
02/2009
1Pathologic Complete Response
01/2009
1Paraproteinemias (Monoclonal Gammopathy)
01/2009
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2004
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2002
1Edema (Dropsy)
04/2001
1Capillary Leak Syndrome
04/2001
1Hypoalbuminemia
04/2001
1Myalgia
04/2001
1Pain (Aches)
04/2001

Drug/Important Bio-Agent (IBA)

4Rituximab (Mabthera)FDA Link
03/2014 - 03/2004
1Alkylating AgentsIBA
03/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2010
1Lenalidomide (CC 5013)FDA Link
03/2010
1Isoproterenol (Isoprenaline)FDA LinkGeneric
02/2009
1Amyloid (Amyloid Fibrils)IBA
01/2009
1Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2007
1GemcitabineFDA Link
08/2007
1InterferonsIBA
04/2002
11- arabinofuranosylcytosine- 5'- stearylphosphateIBA
04/2002
1GadoliniumIBA
06/2001
1IfosfamideFDA LinkGeneric
04/2001
1Morphine (MS Contin)FDA LinkGeneric
04/2001
1Vinorelbine (Navelbine)FDA LinkGeneric
04/2001
1Mitoguazone (MGBG)IBA
04/2001
1Etoposide (VP 16)FDA LinkGeneric
04/2001
1Pharmaceutical PreparationsIBA
04/2001
1Creatine Kinase (Creatine Phosphokinase)IBA
04/2001

Therapy/Procedure

5Therapeutics
07/2016 - 03/2004
2Drug Therapy (Chemotherapy)
04/2003 - 04/2001
1Stem Cell Transplantation
07/2016
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2016
1Transplantation
03/2004
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
03/2004
1Aftercare (After-Treatment)
06/2001
1MINE regimen
04/2001